| 25 May 2026 |
Dianabol Raw |
4.0 |
100g |
86.8g |
-13.2% |
97.02% |
Lab C |
| 25 May 2026 |
Letrozole |
7.8 |
20mg |
24.2mg |
+21.2% |
96.87% |
Lab F |
| 24 May 2026 |
BPC-157 Arg Oral |
9.6 |
100mg |
114.1mg |
+14.1% |
96.23% |
Lab F |
| 24 May 2026 |
Methylene Blue |
7.3 |
50mg |
43.7mg |
-12.6% |
95.65% |
Lab A |
| 24 May 2026 |
17a-Methyl-1-Testosterone |
8.2 |
50mg |
43.2mg |
-13.7% |
97.77% |
Lab B |
| 24 May 2026 |
RIPEX 225 (TRA/Mast P/Test P) |
6.6 |
250mg/ml |
275.9mg/ml |
+10.3% |
97.57% |
Lab C |
| 24 May 2026 |
NA Semax Amidate |
5.3 |
15mg |
18.2mg |
+21.3% |
95.08% |
Lab E |
| 24 May 2026 |
P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 |
7.2 |
5g |
4.4g |
-12.8% |
99.46% |
Lab C |
| 24 May 2026 |
Trenbolone Acetate |
8.3 |
100mg/ml |
114.5mg/ml |
+14.5% |
99.57% |
Lab E |
| 23 May 2026 |
Pinealon |
4.0 |
20mg |
24.3mg |
+21.4% |
99.13% |
Lab A |
| 21 May 2026 |
NAD+ |
7.5 |
5mg |
5.0mg |
-0.7% |
95.78% |
Lab G |
| 20 May 2026 |
5-amino-1MQ |
4.3 |
10mg |
12.5mg |
+24.6% |
95.14% |
Lab E |
| 20 May 2026 |
Tamoxifen (Nolvadex) Raw |
7.9 |
100g |
92.9g |
-7.1% |
99.36% |
Lab B |
| 19 May 2026 |
BPC157 5mg + TB500 5mg Blend |
4.6 |
50mg |
51.7mg |
+3.4% |
96.95% |
Lab C |
| 19 May 2026 |
PE 22-28 |
7.2 |
5mg |
5.7mg |
+13.3% |
97.01% |
Lab C |
| 17 May 2026 |
Dapoxetine |
5.5 |
25mg |
21.3mg |
-14.7% |
95.76% |
Lab E |
| 29 Jan 2026 |
Equipoise (Boldenone Undecylenate) |
4.0 |
100mg/ml |
95.8mg/ml |
-4.2% |
96.59% |
Lab C |
| 29 Jan 2026 |
GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg |
7.1 |
30mg |
26.7mg |
-11.1% |
96.45% |
Lab D |
| 29 Jan 2026 |
MOTS-C |
6.3 |
50mg |
48.6mg |
-2.9% |
95.50% |
Lab D |
| 29 Jan 2026 |
Selank 10mg + Semax 10mg Blend |
6.7 |
2mg |
1.7mg |
-14.9% |
96.97% |
Lab F |
| 7 Jan 2026 |
BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 |
6.6 |
100g |
106.3g |
+6.3% |
97.64% |
Lab E |
| 6 Jan 2026 |
Chonluten |
6.9 |
15mg |
17.6mg |
+17.6% |
99.88% |
Lab D |
| 29 Dec 2025 |
Primobolan Oral (Methenolone Acetate) |
10.0 |
20mg |
22.0mg |
+10.1% |
99.22% |
Lab D |
| 29 Dec 2025 |
Superdrol |
5.4 |
10mg |
8.8mg |
-12.2% |
99.07% |
Lab A |
| 12 Dec 2025 |
EPO |
4.0 |
50mg |
58.0mg |
+15.9% |
97.65% |
Lab C |
| 5 Dec 2025 |
CJC-1295 With DAC |
5.9 |
30mg |
32.7mg |
+8.9% |
98.53% |
Lab F |
| 5 Dec 2025 |
Orforglipron |
5.2 |
10mg |
10.0mg |
+0.3% |
95.77% |
Lab D |
| 5 Dec 2025 |
Sleep Blend (GABA 100mg+Histidine 100mg+L-Theanine 50mg+Taurine 100mg+Melatonin 2mg) |
4.0 |
200mg/ml |
192.3mg/ml |
-3.9% |
98.75% |
Lab G |
| 23 Nov 2025 |
LGD-4033 (Ligandrol) |
7.5 |
10mg |
11.1mg |
+10.7% |
97.76% |
Lab B |
| 17 Nov 2025 |
Hyaluronic acid |
5.7 |
5mg |
4.7mg |
-5.3% |
95.31% |
Lab D |
| 14 Nov 2025 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
4.0 |
20mg |
18.3mg |
-8.6% |
96.31% |
Lab B |
| 5 Nov 2025 |
KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg |
8.9 |
30mg |
31.2mg |
+4.1% |
95.29% |
Lab C |
| 5 Nov 2025 |
Prostamax |
8.7 |
20mg |
23.0mg |
+15.1% |
97.43% |
Lab A |
| 5 Nov 2025 |
Vilon |
8.0 |
5mg |
5.7mg |
+14.4% |
96.15% |
Lab F |
| 4 Nov 2025 |
AHK-CU |
7.8 |
10mg |
9.9mg |
-0.9% |
95.45% |
Lab G |
| 4 Nov 2025 |
Semaglutide Oral |
9.5 |
20mg |
21.8mg |
+8.8% |
96.72% |
Lab F |
| 17 Oct 2025 |
Dianabol |
4.0 |
10mg |
8.8mg |
-12.3% |
96.10% |
Lab F |
| 9 Oct 2025 |
NandroMix 300 |
6.0 |
100mg/ml |
99.9mg/ml |
-0.1% |
97.16% |
Lab E |
| 9 Oct 2025 |
Retatrutide 30mg Pen Kit |
5.7 |
30mg |
26.5mg |
-11.6% |
96.68% |
Lab F |
| 10 Jul 2025 |
GHK-Cu |
6.5 |
150mg |
110mg |
-26.7% |
99.72% |
Lab E |
| 10 Jul 2025 |
GHK-Cu |
7.2 |
150mg |
122mg |
-18.7% |
99.91% |
Lab E |
| 21 May 2025 |
PT-141 |
5.6 |
8mg |
11.25mg |
+40.6% |
99.44% |
Lab D |
| 21 May 2025 |
PT-141 |
5.8 |
8mg |
11.39mg |
+42.4% |
99.55% |
Lab D |
| 20 May 2025 |
GHK-Cu |
7.6 |
150mg |
135.48mg |
-9.7% |
99.52% |
Lab D |
| 20 May 2025 |
BPC-157 |
7.3 |
6mg |
6.54mg |
+9.0% |
99.30% |
Lab D |
| 20 May 2025 |
Melanotan II |
6.3 |
8mg |
10.75mg |
+34.4% |
99.67% |
Lab D |